VTechWorks staff will be away for the Thanksgiving holiday beginning at noon on Wednesday, November 27, through Friday, November 29. We will resume normal operations on Monday, December 2. Thank you for your patience.
 

Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: A review

Simple item page
dc.contributor.authorFazili, Tasaduqen
dc.contributor.authorBansal, Ekta N.en
dc.contributor.authorGarner, Dorothyen
dc.contributor.authorGomez, Marianaen
dc.contributor.authorStornelli, Nicholasen
dc.date.accessioned2023-02-09T19:33:56Zen
dc.date.available2023-02-09T19:33:56Zen
dc.date.issued2023-02en
dc.date.updated2023-02-09T18:03:53Zen
dc.description.abstractDalbavancin is a parenteral lipoglycopeptide antibiotic derived from teicoplanin, an analog of vancomycin. It is mainly used for skin and soft tissue infections. The sustained half-life of around 14 days makes dalbavancin a novel option for potential use as sequential treatment in infections like infective endocarditis, which require prolonged antibiotic courses. However, only a few studies have been reported in the literature and its use remains limited. We reviewed the currently available literature using dalbavancin in the treatment of infective endocarditis due to Gram-positive organisms. Almost all patients received dalbavancin as sequential therapy following standard of care antibiotics. The overall clinical efficacy was around 90% and it appeared to be well tolerated.en
dc.description.versionAccepted versionen
dc.format.mimetypeapplication/pdfen
dc.identifier106749 (Article number)en
dc.identifier.doihttps://doi.org/10.1016/j.ijantimicag.2023.106749en
dc.identifier.issn0924-8579en
dc.identifier.orcidGomez, Mariana [0000-0001-8963-9959]en
dc.identifier.urihttp://hdl.handle.net/10919/113754en
dc.language.isoenen
dc.publisherElsevieren
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.titleDalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: A reviewen
dc.title.serialInternational Journal of Antimicrobial Agentsen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicine/Infectious Diseaseen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms.pdf
Size:
707.38 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

All Faculty Deposits
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)